Masimo v Apple; mRNA battles; patent transactions data; latest Nokia injunction; IBM’s new CIPO; plus much more

Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week.

MONDAY 10 April

Data dive: Masimo and Apple patent duel heats up in California courtroom. Read more here

TUESDAY 11 April

New Pfizer/BioNTech covid-19 lawsuit adds to complex web of mRNA disputes. Read more here

Data dive: Patent transactions plummet in Q4 2022 compared to same period in 2021. Read more here


New rules in India allowing foreign lawyers met with mixed reaction in IP community. Read more here

Nokia wins German injunction against Vivo, mirroring Oppo dispute. Read more here

IAM’s top takeaways from day one of IPBC Europe 2023. Read more here             


Weekly column: On both sides of the Atlantic, patent policy is dictated by deep pockets not evidence. Read more here

Bristol-Myers Squibb and Dana-Farber settle landmark dispute. Read more here

Chinese mega-manufacturer TCL signs with Via Licensing. Read more here

FRIDAY 14 April

Madras High Court’s new IP division opens doors. Read more here

Interview: Meet the new leader of IBM’s IP monetisation team. Read more here

IPBC Europe day two key highlights. Read more here


Opinion: Delaware judge's inquisition is headed down a dangerous path. Read more here

Unlock unlimited access to all IAM content